1130P Impact of molecular HRD testing on ovarian cancer patient treatment and survival: A nationwide study of 2087 patients.
Saved in:
| Title: | 1130P Impact of molecular HRD testing on ovarian cancer patient treatment and survival: A nationwide study of 2087 patients. |
|---|---|
| Authors: | Romey, M.1 (AUTHOR), Rodepeter, F.2 (AUTHOR), Hattesohl, A.1 (AUTHOR), Grass, A.2 (AUTHOR), Heitz, F.3 (AUTHOR), Bösmüller, H.4 (AUTHOR), Harter, P.5 (AUTHOR), Kommoss, S.6 (AUTHOR), Marmé, F.7 (AUTHOR), Wagner, U.8 (AUTHOR), Timms, K.9 (AUTHOR), Gremke, N.8 (AUTHOR), Denkert, C.2 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS751-S751. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1766 |
